VentureBeat

Signifier Medical Technologies Raises $35M in Series D Funding Round to Accelerate Commercialization of eXciteOSA Therapy

Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in its Series D capital raise. This ...
Business Wire

Signifier Medical Technologies Announces Publication of a New Study Exploring Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive ...

BOSTON & LONDON--(BUSINESS WIRE)--Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announces that The International Journal of Technology ...
FierceBiotech

Signifier hypes up eXcite tongue stimulation device for sleep apnea with $35M series D

Forget counting sheep—Signifier Medical Technologies now has about 35 million other things to tally up in its mission to build devices to improve sleep-disordered breathing. The London-based company ...
Business Wire

Signifier Medical Technologies’ eXciteOSA Now Covered by Medicaid in South Carolina: Reaching a Wider Patient Population with Daytime Sleep Apnea Therapy

BOSTON--(BUSINESS WIRE)--Signifier Medical Technologies Limited (“Signifier”), a leader in medical technology for sleep-disordered breathing, is thrilled to announce that eXciteOSA therapy is now ...
Financial Post

Signifier Medical Introduces New eXciteOSA® Product Update, Expanding Access to Sleep Apnea Therapy for More Medicare and Medicaid Patients

LONDON — Signifier Medical Technologies Limited (“Signifier”), a global leader in medical technology for sleep-disordered breathing, today announced the introduction of its newest SKU, 18010, which ...